SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $139,000 | -2.1% | 10,678 | -17.3% | 0.01% | 0.0% |
| Q1 2016 | $142,000 | -43.4% | 12,918 | -52.7% | 0.01% | -45.5% |
| Q4 2015 | $251,000 | +19.0% | 27,314 | -10.2% | 0.01% | +22.2% |
| Q3 2015 | $211,000 | -31.7% | 30,416 | -3.3% | 0.01% | -18.2% |
| Q2 2015 | $309,000 | -13.0% | 31,463 | -21.5% | 0.01% | -8.3% |
| Q1 2015 | $355,000 | +42.6% | 40,055 | +41.1% | 0.01% | +50.0% |
| Q4 2014 | $249,000 | -12.6% | 28,389 | -31.3% | 0.01% | -11.1% |
| Q3 2014 | $285,000 | +18.3% | 41,299 | -9.8% | 0.01% | +28.6% |
| Q2 2014 | $241,000 | -15.4% | 45,772 | -27.0% | 0.01% | -12.5% |
| Q1 2014 | $285,000 | +203.2% | 62,713 | +234.6% | 0.01% | +166.7% |
| Q4 2013 | $94,000 | -1.1% | 18,742 | 0.0% | 0.00% | +50.0% |
| Q3 2013 | $95,000 | +30.1% | 18,742 | +28.1% | 0.00% | 0.0% |
| Q2 2013 | $73,000 | – | 14,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |